ADMET and Insilico docking Studies of Erlotinib Leads with EGFR Protein for the Treatment of Lung Cancer.

Soundarya K

ADMET and Insilico docking Studies of Erlotinib Leads with EGFR Protein for the Treatment of Lung Cancer. - DCB